Investor profile
JamJar Investments
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
JamJar Investments is an early-stage European consumer venture capital firm founded in 2012 by the co-founders of Innocent Drinks — Richard Reed, Jon Wright, and Adam Balon — alongside partner Katie Marrache. The firm's entire investment philosophy is rooted in the founders' lived experience of building Innocent from a market stall to Europe's number-one juice brand in 15 years, before selling to Coca-Cola for over $700 million. That operational journey — spanning brand-building, commercial scale-up, and international expansion — informs every investment decision JamJar makes, giving portfolio founders access to a team that has genuinely 'been there and done it' in consumer. JamJar's stated mission is to 'love, help and invest in early-stage consumer brands.' The firm looks for three core attributes in prospective investments: a complementary founding team that has proven it can ruthlessly prioritise; a product that consumers genuinely love, evidenced by strong early metrics; and high exit potential, with the ability to reach a £250 million-plus valuation. The firm invests across both physical (FMCG) and digital consumer products, spanning food & beverage, health & beauty, personal care, pet care, travel, leisure, and consumer software. Geographically, JamJar focuses on the UK and broader Europe, deploying Seed and Series A cheques typically in the £500,000–£5 million range. The firm can lead or co-invest, and actively supports portfolio companies with hands-on operational guidance, brand strategy, and commercial introductions — a value-add model modelled on the Innocent playbook. JamJar's second fund, a £100 million vehicle raised in 2022 and cornerstoned by a £48 million commitment from the British Business Bank's Enterprise Capital Funds programme (making it the largest ECF to date), significantly expanded the firm's capacity to back the next generation of category-defining challenger brands across the UK and Europe. JamJar maintains a 50:50 gender balance in its investment team and is committed to placing diversity and equality at the heart of all decision-making. The firm has backed over 100 companies since inception, with notable exits including Deliveroo (IPO), Oatly (NASDAQ IPO), Wild (acquired by Unilever), Graze (acquired by Katjes International), and Songkick (acquired). The portfolio spans consumer technology, FMCG, health & wellness, and sustainability-led brands, reflecting JamJar's belief that the best consumer brands of tomorrow will combine product excellence, authentic storytelling, and a clear positive impact on people's lives.
Notable quotes
“'The product is the brand. You can spend a long time crafting how it looks and sounds rather than what it is.'”
“'JamJar is looking forward to helping new category-defining brands win their fight.'”
“'It's solving a consumer problem… with a brand that gives people moments of delight, that unlocks the magic.'”
“'We're excited to back Humantra as they set a new standard for hydration. The product is built for all humans.'”
“'We're huge fans of Skin Rocks - an expert-driven brand on a mission to demystify beauty and make skincare make sense.'”
Team
Richard Reed
Co-Founder & Partner
Jon Wright
Co-Founder & Partner
Veeraje Bhonsle
Investor
Victoria Imerelli
Investor
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Shellworks | Series A | $15m | 2026-03-09 |
| Equa.ls | Seed | — | 2026-02-25 |
| TrueStart Coffee | Series A | — | 2026-01-29 |
| Marleybones | Seed | $3m | 2025-10-29 |
| Humantra | Seed | — | 2025-05-28 |
| Skin Rocks | Seed | — | 2025-04-30 |
| Yepoda | Series B | — | 2025-03-21 |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| V3 Ventures | 2 |
| Redrice Ventures | 1 |
| Verlinvest | 1 |
| DLF Venture | 1 |
| Active Partners | 1 |
| Slingshot Ventures | 1 |
| Pembroke VCT | 1 |
Fit check
Is JamJar Investments a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit